The road ahead: a brief guide to navigating the 2022 WHO classification of endocrine and neuroendocrine tumoursCarl Christofer Juhlin
9 July 2024
Histological features of liver disease development in the Atp7b mouse: a model of Wilson’s diseasePierre-Marie Lavrut, Olivier Guillaud, Jérôme Dumortier, Elisabeth Mintz, Virginie Brun, Sophie Heissat, Eduardo Couchonnal Bedoya, Alain Lachaux, Muriel Bost, Valerie Hervieu
15 November 2023
Primary desmoplastic small round cell tumour of the prostateJingyu Qian, Yanjin Yang, Xin Xie, Yifan Kang, Jinjing Zhong, Xueqin Chen, Ni Chen, Qiao Zhou, Ling Nie
29 July 2024
Sunitinib induced glomerular thrombotic microangiopathy in a patient with refractory pancreatic neuroendocrine tumourAisha Khan, Margarita Consing Gangelhoff, Simon Moubarak, Sandra Herrmann, Karim Nooruddin, Mariam Alexander
14 December 2024
Lymphoid enhancer-binding factor 1 (LEF1) immunostaining as a surrogate for β-catenin (CTNNB1) mutationsEkkehard Hewer, Pascal David Fischer, Erik Vassella, Laura Knabben, Sara Imboden, Michael D Mueller, Tilman T Rau, Matthias S Dettmer
9 December 2024
Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use caseGiorgio Cazzaniga, Francesco Mascadri, Stefano Marletta, Alessandro Caputo, Gabriele Guidi, Giovanni Gambaro, Albino Eccher, Angelo Paolo Dei Tos, Fabio Pagni, Vincenzo L'Imperio
27 March 2024
SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinomaYue Xu, Zihan Quan, Yuting Zhan, Haihua Wang, Jiadi Luo, Weiyuan Wang, Songqing Fan
27 September 2023
Partial regression of conventional renal cell carcinoma displays markers of wound repairLilla Domonkos, Maria Yusenko, Gyula Kovacs, Daniel Banyai
21 October 2024
Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithmsAida Molero, Susana Hernandez, Marta Alonso, Melina Peressini, Daniel Curto, Fernando Lopez-Rios, Esther Conde
17 October 2024
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort studyFederica Miglietta, Valentina Carraro, Ottavia Amato, Gaia Griguolo, Michele Bottosso, Giada Munari, Giovanni Zarrilli, Marcello Lo Mele, Caterina Barbieri, Angelo Paolo Dei Tos, Valentina Guarneri, Maria Vittoria Dieci, Matteo Fassan
21 June 2023